350.16
Intuitive Surgical Inc stock is traded at $350.16, with a volume of 3.19M.
It is down -4.51% in the last 24 hours and down -7.56% over the past month.
Intuitive develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 10,000 da Vinci systems in hospitals worldwide, with more than 6,000 installations in the US and a growing number in emerging markets.
See More
Previous Close:
$366.70
Open:
$361.305
24h Volume:
3.19M
Relative Volume:
1.08
Market Cap:
$123.70B
Revenue:
$11.03B
Net Income/Loss:
$3.16B
P/E Ratio:
40.13
EPS:
8.7251
Net Cash Flow:
$3.22B
1W Performance:
-5.17%
1M Performance:
-7.56%
6M Performance:
-28.56%
1Y Performance:
-25.50%
Intuitive Surgical Inc Stock (ISRG) Company Profile
Name
Intuitive Surgical Inc
Sector
Industry
Phone
(408) 523-2100
Address
1020 KIFER ROAD, SUNNYVALE
Compare ISRG vs BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
ISRG
Intuitive Surgical Inc
|
350.16 | 129.55B | 11.03B | 3.16B | 3.22B | 8.7251 |
|
BDX
Becton Dickinson Co
|
179.10 | 50.32B | 21.37B | 1.41B | 3.07B | 3.9437 |
|
ALC
Alcon Inc
|
69.12 | 34.08B | 10.63B | 819.00M | 1.59B | 1.6577 |
|
RMD
Resmed Inc
|
221.05 | 32.94B | 5.54B | 1.52B | 1.74B | 10.37 |
|
MDLN
Medline Inc
|
34.69 | 32.10B | 29.14B | 1.07B | 1.05B | 1.1956 |
Intuitive Surgical Inc Stock (ISRG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-26 | Upgrade | Citigroup | Neutral → Buy |
| Jan-27-26 | Initiated | TD Cowen | Buy |
| Dec-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Jul-23-25 | Downgrade | Erste Group | Buy → Hold |
| Jun-09-25 | Downgrade | Deutsche Bank | Hold → Sell |
| Jun-05-25 | Upgrade | Erste Group | Hold → Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-02-24 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Jul-10-24 | Reiterated | Citigroup | Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Nov-17-23 | Initiated | HSBC Securities | Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Apr-19-23 | Reiterated | BTIG Research | Buy |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Evercore ISI | In-line |
| Apr-19-23 | Reiterated | JP Morgan | Overweight |
| Apr-19-23 | Reiterated | Morgan Stanley | Equal-Weight |
| Apr-19-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-19-23 | Reiterated | Raymond James | Outperform |
| Apr-19-23 | Reiterated | Stifel | Buy |
| Apr-19-23 | Reiterated | Truist | Buy |
| Apr-19-23 | Reiterated | Wells Fargo | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-23-23 | Initiated | William Blair | Outperform |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-13-22 | Initiated | Mizuho | Neutral |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Mar-25-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-25-22 | Downgrade | Redburn | Buy → Neutral |
| Jan-21-22 | Reiterated | BTIG Research | Buy |
| Jan-21-22 | Upgrade | Citigroup | Neutral → Buy |
| Jan-21-22 | Reiterated | Deutsche Bank | Hold |
| Jan-21-22 | Reiterated | Evercore ISI | In-line |
| Jan-21-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-21-22 | Reiterated | Piper Sandler | Neutral |
| Jan-21-22 | Reiterated | Raymond James | Outperform |
| Jan-21-22 | Reiterated | Robert W. Baird | Outperform |
| Jan-21-22 | Reiterated | Stifel | Buy |
| Jan-21-22 | Reiterated | UBS | Neutral |
| Jan-21-22 | Reiterated | Wells Fargo | Overweight |
| Jan-10-22 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-01-21 | Downgrade | Citigroup | Buy → Neutral |
| Jul-21-21 | Reiterated | BofA Securities | Neutral |
| Jul-21-21 | Reiterated | Citigroup | Buy |
| Jul-21-21 | Reiterated | JP Morgan | Overweight |
| Jul-21-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Jul-21-21 | Reiterated | Piper Sandler | Neutral |
| Jul-21-21 | Reiterated | SVB Leerink | Mkt Perform |
| Jul-21-21 | Reiterated | Stifel | Buy |
| Jul-21-21 | Reiterated | UBS | Neutral |
| Jul-21-21 | Reiterated | Wells Fargo | Overweight |
| Jul-14-21 | Reiterated | Goldman | Buy |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Apr-21-21 | Upgrade | Oppenheimer | Underperform → Perform |
| Apr-21-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Apr-01-21 | Initiated | Citigroup | Buy |
| Dec-15-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Sep-28-20 | Initiated | Argus | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Outperform |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Jul-20-20 | Reiterated | Bernstein | Outperform |
| Apr-28-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Apr-17-20 | Downgrade | CFRA | Hold → Sell |
| Apr-17-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-09-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Apr-01-20 | Downgrade | Oppenheimer | Perform → Underperform |
| Jan-27-20 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-19 | Reiterated | Wells Fargo | Outperform |
| Nov-21-19 | Initiated | Oppenheimer | Perform |
| Jul-19-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-22-19 | Reiterated | Canaccord Genuity | Buy |
| Apr-02-19 | Initiated | Deutsche Bank | Buy |
| Oct-31-18 | Reiterated | Piper Jaffray | Overweight |
| Oct-19-18 | Upgrade | Canaccord Genuity | Hold → Buy |
View All
Intuitive Surgical Inc Stock (ISRG) Latest News
Intuitive study finds da Vinci surgery linked to shorter stays By Investing.com - Investing.com Canada
A review of 14 million surgeries links robot-assisted surgery to faster recovery - Stock Titan
Intuitive Surgical Inc Stock (ISRG) Moved Down by 4.38% on Sep 8: Drivers Behind the Movement - TradingKey
Intuitive Surgical Stock (ISRG) Opinions on Q2 Earnings and Procedure Slowdown - Quiver Quantitative
Why Intuitive Surgical (ISRG) Stock Is Down Today - Quiver Quantitative
Intuitive Surgical stock gains support as BTIG reiterates buy rating and strong Q2 2026 growth - ad-hoc-news.de
The Zacks Analyst Blog Highlights FANUY, ABBNY, KYCCF, NVDA, ISRG, ILMN, NOVT, BOTZ, ROBO, ROBT and IBOT - Zacks Investment Research
ISRG Reiterated by BTIG -- Rating Maintained at Buy - GuruFocus
Intuitive Surgical stock heads into the open after a 2.9% drop - ad-hoc-news.de
Formuepleje A S Has $1.33 Million Stake in Intuitive Surgical, Inc. $ISRG - InsuranceNewsNet
ISRG's Ion Platform Is Quietly Becoming a Second Growth Engine - TradingView
Intuitive Surgical stock steadies after strong Q2 earnings beat - AD HOC NEWS
Intuitive Surgical (ISRG): Embracing AI Innovations in Robotic Surgery for Future Growth - Yahoo Finance
Intuitive Surgical, Inc. (ISRG) Stock Analysis: A 30% Upside Potential Beckons Investors - DirectorsTalk Interviews
Why Is ISRG in Focus Across the Nasdaq Composite This Week? - Kalkine Media
Intuitive Surgical stock heads into the open after a 2.9% slide - ad-hoc-news.de
Intuitive Surgical (ISRG) Down 30% This Year; Can Tonight’s Q2 Earnings Reverse the Bearish Channel? - TradingKey
Intuitive Surgical's Growth Has Cooled From Its Post-Pandemic Highs. Is That a Buying Opportunity or a Warning? - Yahoo Finance
Intuitive Surgical stock gains on strong Q2 2026 margins and recurring revenue - AD HOC NEWS
Intuitive Surgical Vs. Stryker: Wall Street Loves Both But One Has a Quiet Advantage That Will Make Investors Money - Yahoo Finance
Intuitive Surgical stock steadies ahead of Q2 2026 earnings report - AD HOC NEWS
SS Innovations International (NASDAQ: SSII) Highlighted as Stronger Growth Opportunity in Seeking Alpha Analysis - TradingView
How India built a new model for robotic surgery: Insights from Dr. Mahendra Bhandari and Siddharth Siva - The American Bazaar
Intuitive Surgical Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Medtronic Tops Earnings Estimates and Makes $700M Robot Surgeon Investment. Is It Gaining on Intuitive Surgical? - Barron's
What Is Shaping Interest in Intuitive Surgical? (NASDAQ:ISRG) - Kalkine Media
How Is Intuitive Surgical's Stock Performance Compared to Other Health Care Equipment Stocks? - Barchart.com
Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds? - TradingView
Intuitive Surgical stock trades well below its 52-week high as Q2 2026 growth supports da Vinci outl - AD HOC NEWS
Intuitive Surgical Inc. stock outperforms competitors on strong trading day - MarketWatch
Intuitive Surgical Vs. SS Innovations: Why You Should Buy The Lesser-Known Indian Competitor - Seeking Alpha
Intuitive Surgical (ISRG) Q2 2026 Earnings Call Transcript - fortune.com
Intuitive Surgical stock holds at $372 as da Vinci platform expands in robotic surgery - AD HOC NEWS
Intuitive Surgical (ISRG) Q1 2026 Earnings Call Transcript - Fortune
Intuitive Surgical, Inc. (ISRG) Stock Analysis: A Closer Look At Its 28.29% Potential Upside - DirectorsTalk Interviews
Intuitive Surgical (ISRG) Pours Record Cash Flow Into 100 Plus Da Vinci 5 Upgrades - Sahm
Intuitive Surgical's Record Cash Flow Gives It an Innovation Advantage - TradingView
ISRG vs. MDT: Which Surgical Robot Stock Is the Smarter Buy? - TradingView
Intuitive - Forbes
Intuitive Surgical Inc. stock underperforms Monday when compared to competitors - MarketWatch
Thermo Fisher vs. Intuitive Surgical: Which Premium Healthcare Stock Deserves its Valuation? - Yahoo Finance
How Slowing US Bariatric Procedures and Capital Constraints Will Impact Intuitive Surgical (ISRG) Investors - Yahoo Finance UK
Intuitive surgical EVP Mark Brosius sells $59,439 in stock - Investing.com
Intuitive surgical EVP Mark Brosius sells $59,439 in stock By Investing.com - Investing.com Canada
Mark Brosius Sells 77 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock - MarketBeat
Intuitive Surgical (NASDAQ: ISRG) EVP sells under 10b5-1 plan - Stock Titan
$1000 Invested In Intuitive Surgical 20 Years Ago Would Be Worth This Much Today - Benzinga
Intuitive Surgical Stock Has Fallen While Its Operating Margin Keeps Widening - Trefis
Piper Sandler reiterates Intuitive Surgical stock rating at overweight - Investing.com
Piper Sandler reiterates Intuitive Surgical stock rating at overweight By Investing.com - Investing.com India
Is Wall Street Bullish or Bearish on Intuitive Surgical Stock? - Barchart.com
Intuitive Surgical Inc Stock (ISRG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):